Skip to content

CeriBell, Inc. CBLL Enterprise value

Enterprise value at other companies

IAR
Integra LifeSciencesIART
$2.47B-26.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$297.01M-7.1%
iRadimed logo
iRadimedIRMD
$617.02M+20.1%
Teladoc Health logo
Teladoc HealthTDOC
$263.76M-66.3%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
$1.19B
Cerence Inc. logo
Cerence Inc.CRNC
$363.35M-27.4%

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s enterprise value?
CeriBell, Inc. (CBLL) reported enterprise value of $666.83M in Q1 2026.
How has CeriBell, Inc.'s enterprise value changed year-over-year?
CeriBell, Inc.'s enterprise value increased by 19.6% year-over-year, from $557.43M to $666.83M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.